Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: A perfusion SPECT study

R. Cilia, G. Marotta, A. Landi, I. U. Isaias, F. Vergani, R. Benti, E. Sganzerla, P. Gerundini, G. Pezzoli, A. Antonini

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Extradural motor cortex stimulation (EMCS) has been proposed as alternative to deep brain stimulation (DBS) in the treatment of Parkinson's disease (PD). Its mechanisms of action are still unclear. Neuroimaging evidenced motor cortical dysfunction in PD that can be reversed by therapy. We performed left hemisphere EMCS surgery in six advanced PD patients fulfilling CAPSIT criteria for DBS with the exception of age >70 years. After 6 months, we measured regional cerebral blood flow (rCBF) at rest with SPECT and Tc-99m cysteinate dimer bicisate off-medication with stimulator off and on. Clinical assessment included Unified Parkinson's Disease Rating Scale part II and III, Abnormal Involuntary Movement Scale and mean dopaminergic medication dosage. We used statistical parametric mapping for imaging data analysis. Clinically we observed no mean changes in motor scales, although blinded evaluation revealed some benefit in individual patients. We found significant rCBF decrements in the pre-central gyrus, pre-motor cortex and caudate nucleus bilaterally, left prefrontal areas and right thalamus. Perfusion increments were found in cerebellum bilaterally. EMCS determined significant modulation of neuronal activity within the cortico-basal ganglia-thalamo-cortical motor loop in our cohort of advanced PD patients. However, these effects were paralleled by mild and variable clinical efficacy.

Original languageEnglish
Pages (from-to)18-24
Number of pages7
JournalEuropean Journal of Neurology
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Motor Cortex
Single-Photon Emission-Computed Tomography
Parkinson Disease
Perfusion
Cerebrovascular Circulation
Deep Brain Stimulation
Regional Blood Flow
Caudate Nucleus
Basal Ganglia
Thalamus
Neuroimaging
Cerebellum
Therapeutics

Keywords

  • Cerebral blood flow
  • Extradural motor cortex stimulation
  • Parkinson's disease
  • SPECT imaging

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease : A perfusion SPECT study. / Cilia, R.; Marotta, G.; Landi, A.; Isaias, I. U.; Vergani, F.; Benti, R.; Sganzerla, E.; Gerundini, P.; Pezzoli, G.; Antonini, A.

In: European Journal of Neurology, Vol. 15, No. 1, 01.2008, p. 18-24.

Research output: Contribution to journalArticle

Cilia, R. ; Marotta, G. ; Landi, A. ; Isaias, I. U. ; Vergani, F. ; Benti, R. ; Sganzerla, E. ; Gerundini, P. ; Pezzoli, G. ; Antonini, A. / Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease : A perfusion SPECT study. In: European Journal of Neurology. 2008 ; Vol. 15, No. 1. pp. 18-24.
@article{66d152e4f91d4406807fb9be5362b5c1,
title = "Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: A perfusion SPECT study",
abstract = "Extradural motor cortex stimulation (EMCS) has been proposed as alternative to deep brain stimulation (DBS) in the treatment of Parkinson's disease (PD). Its mechanisms of action are still unclear. Neuroimaging evidenced motor cortical dysfunction in PD that can be reversed by therapy. We performed left hemisphere EMCS surgery in six advanced PD patients fulfilling CAPSIT criteria for DBS with the exception of age >70 years. After 6 months, we measured regional cerebral blood flow (rCBF) at rest with SPECT and Tc-99m cysteinate dimer bicisate off-medication with stimulator off and on. Clinical assessment included Unified Parkinson's Disease Rating Scale part II and III, Abnormal Involuntary Movement Scale and mean dopaminergic medication dosage. We used statistical parametric mapping for imaging data analysis. Clinically we observed no mean changes in motor scales, although blinded evaluation revealed some benefit in individual patients. We found significant rCBF decrements in the pre-central gyrus, pre-motor cortex and caudate nucleus bilaterally, left prefrontal areas and right thalamus. Perfusion increments were found in cerebellum bilaterally. EMCS determined significant modulation of neuronal activity within the cortico-basal ganglia-thalamo-cortical motor loop in our cohort of advanced PD patients. However, these effects were paralleled by mild and variable clinical efficacy.",
keywords = "Cerebral blood flow, Extradural motor cortex stimulation, Parkinson's disease, SPECT imaging",
author = "R. Cilia and G. Marotta and A. Landi and Isaias, {I. U.} and F. Vergani and R. Benti and E. Sganzerla and P. Gerundini and G. Pezzoli and A. Antonini",
year = "2008",
month = "1",
doi = "10.1111/j.1468-1331.2007.01993.x",
language = "English",
volume = "15",
pages = "18--24",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease

T2 - A perfusion SPECT study

AU - Cilia, R.

AU - Marotta, G.

AU - Landi, A.

AU - Isaias, I. U.

AU - Vergani, F.

AU - Benti, R.

AU - Sganzerla, E.

AU - Gerundini, P.

AU - Pezzoli, G.

AU - Antonini, A.

PY - 2008/1

Y1 - 2008/1

N2 - Extradural motor cortex stimulation (EMCS) has been proposed as alternative to deep brain stimulation (DBS) in the treatment of Parkinson's disease (PD). Its mechanisms of action are still unclear. Neuroimaging evidenced motor cortical dysfunction in PD that can be reversed by therapy. We performed left hemisphere EMCS surgery in six advanced PD patients fulfilling CAPSIT criteria for DBS with the exception of age >70 years. After 6 months, we measured regional cerebral blood flow (rCBF) at rest with SPECT and Tc-99m cysteinate dimer bicisate off-medication with stimulator off and on. Clinical assessment included Unified Parkinson's Disease Rating Scale part II and III, Abnormal Involuntary Movement Scale and mean dopaminergic medication dosage. We used statistical parametric mapping for imaging data analysis. Clinically we observed no mean changes in motor scales, although blinded evaluation revealed some benefit in individual patients. We found significant rCBF decrements in the pre-central gyrus, pre-motor cortex and caudate nucleus bilaterally, left prefrontal areas and right thalamus. Perfusion increments were found in cerebellum bilaterally. EMCS determined significant modulation of neuronal activity within the cortico-basal ganglia-thalamo-cortical motor loop in our cohort of advanced PD patients. However, these effects were paralleled by mild and variable clinical efficacy.

AB - Extradural motor cortex stimulation (EMCS) has been proposed as alternative to deep brain stimulation (DBS) in the treatment of Parkinson's disease (PD). Its mechanisms of action are still unclear. Neuroimaging evidenced motor cortical dysfunction in PD that can be reversed by therapy. We performed left hemisphere EMCS surgery in six advanced PD patients fulfilling CAPSIT criteria for DBS with the exception of age >70 years. After 6 months, we measured regional cerebral blood flow (rCBF) at rest with SPECT and Tc-99m cysteinate dimer bicisate off-medication with stimulator off and on. Clinical assessment included Unified Parkinson's Disease Rating Scale part II and III, Abnormal Involuntary Movement Scale and mean dopaminergic medication dosage. We used statistical parametric mapping for imaging data analysis. Clinically we observed no mean changes in motor scales, although blinded evaluation revealed some benefit in individual patients. We found significant rCBF decrements in the pre-central gyrus, pre-motor cortex and caudate nucleus bilaterally, left prefrontal areas and right thalamus. Perfusion increments were found in cerebellum bilaterally. EMCS determined significant modulation of neuronal activity within the cortico-basal ganglia-thalamo-cortical motor loop in our cohort of advanced PD patients. However, these effects were paralleled by mild and variable clinical efficacy.

KW - Cerebral blood flow

KW - Extradural motor cortex stimulation

KW - Parkinson's disease

KW - SPECT imaging

UR - http://www.scopus.com/inward/record.url?scp=37249075927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249075927&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2007.01993.x

DO - 10.1111/j.1468-1331.2007.01993.x

M3 - Article

AN - SCOPUS:37249075927

VL - 15

SP - 18

EP - 24

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -